Fig. 1From: Lung stereotactic body radiation therapy for elderly patients aged ≥ 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort studyLocal control and survival rates after stereotactic body radiotherapy. (a) Local control, (b) cancer-specific survival, (c) progression-free survival, and (d) overall survivalBack to article page